Global Chloroquine Phosphate Market Outlook 2022

Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Middle East and Africa is the dominant market in the global Chloroquine Phosphate market in terms of value. Sanofi and Bayer are the two players with the largest sales share, occupying 9.24% and 8.36% of the market share in 2019, respectively. And It is worth of noticing that chloroquine phosphate used in COVID-2019 will occupy 24.58% of the market share in 2020.

The global Chloroquine Phosphate market was valued at US$ 189 million in 2020 and is expected to reach US$ 66 million by the end of 2027, growing at a CAGR of -11.4% during 2021-2027.
This report focuses on Chloroquine Phosphate volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Chloroquine Phosphate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Chloroquine Phosphate Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Chloroquine Phosphate Injectable
Chloroquine Phosphate Oral

Segment by Application
Malaria
COVID-19
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Sanofi
Bayer
Ipca Laboratories
Cipla
Teva Pharmaceuticals
Merck
AstraZeneca
Pharco Pharmaceuticals
Indofarma
Jayson Pharmaceuticals
AM-Europharma
Humax Pharmaceutical
Atlantic Pharmaceutical
Ace Pharmaceuticals BV

Frequently Asked Questions